Printer Friendly

CORTECH COMPLETES COMMON STOCK OFFERING

 DENVER, Oct. 26 /PRNewswire/ -- Cortech Inc. (NASDAQ: CRTQ) announced today a common stock offering of 2,350,000 shares of common stock at an offering price of $15 per share, according to David K. Crossen, president and chief executive officer. Montgomery Securities and Hambrecht & Quist Inc. are underwriters of the offering.
 All of the shares are being issued by the company. The company also has granted the underwriters an option to purchase an additional 352,500 shares to cover over-allotments.
 Cortech is a biopharmaceutical company focused on the design and development of three novel classes of drugs -- bradykinin antagonists, neutrophil elastase inhibitors and antigen-specific immunomodulators -- to treat a broad range of inflammatory and immune disorders.
 The offering of Cortech securities is made only by means of the prospectus. A copy of the final prospectus relating to these securities is available from Montgomery Securities, 600 Montgomery St., San Francisco, CA 94111; or from Hambrecht & Quist Inc., One Bush St., San Francisco, CA 94104.
 -0- 10/26/93
 /CONTACT: David K. Crossen or Joseph L. Turner of Cortech, 303-650-1200/
 (CRTQ)


CO: Cortech Inc. ST: Colorado IN: MTC SU: OFR

MC -- DV001 -- 6793 10/26/93 10:06 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 26, 1993
Words:196
Previous Article:STANDARD FEDERAL BANK AND HERITAGE BANKCORP, INC. RECEIVE OTS APPROVAL FOR MERGER
Next Article:OFFICE DEPOT SELLS LIQUID YIELD OPTION(TM) NOTES; NET PROCEEDS OF APPROXIMATELY $160 MILLION
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters